Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
Condition: OsteomalaciaIntervention: Drug: OsteomalaciaSponsors: National Institute of Dental and Craniofacial Research (NIDCR); National Institutes of Health Clinical Center (CC)Recruiting - verified August 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials